Eclipsys Sunrise Clinical Suite chosen by Irvine Medical Center

TriMed Staff | | Health Imaging | Practice Management
Eclipsys Corp. recently announced that the University of California, Irvine Medical Center (UCI Medical Center) has selected multiple products from the company's Sunrise clinical suite of healthcare information technology solutions for activation in 2007 in advance of the opening of UCI's new, state-of-the-art facility in late 2008, the company said.

A long-time user of the Eclipsys 7000 heritage clinical information system, UCI Medical Center will implement the latest version of Sunrise Clinical Manager, as well as other integrated Sunrise advanced clinical solutions: Sunrise ED Manager, Sunrise Medication Manager, Knowledge-Based Charting and Sunrise Ambulatory Care Manager.

TriMed Staff

Related Content

MRI accident has prompted the company that installed the scanner to issue a safety warning
Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.